- Sources of inter-individual variability leading to significant changes in anti-PD-1 and anti-PD-L1 efficacy identified in mouse tumor models using a QSP framework
Jessica C. Leete et al, 2022, Frontiers in Pharmacology CrossRef - Peripheral Blood Transcriptome in Breast Cancer Patients as a Source of Less Invasive Immune Biomarkers for Personalized Medicine, and Implications for Triple Negative Breast Cancer
Helena Čelešnik et al, 2022, Cancers CrossRef - PD-L1, a Potential Immunomodulator Linking Immunology and Orthodontically Induced Inflammatory Root Resorption (OIIRR): Friend or Foe?
Jiawen Yong et al, 2022, International Journal of Molecular Sciences CrossRef - Programmed Cell Death Protein 1 (PD-1) in Relation to PANoptosis: Immune Pharmacological Targets for Management of Breast Adenocarcinoma
Subarnarekha Maitra et al, 2023, Endocrine, Metabolic & Immune Disorders - Drug Targets CrossRef - Case Report: Squamous Cell Carcinoma of Pancreas With High PD-L1 Expression: A Rare Presentation
Baohong Yang et al, 2021, Frontiers in Oncology CrossRef - Nature vs. Nurture: The Two Opposing Behaviors of Cytotoxic T Lymphocytes in the Tumor Microenvironment
Nagaja Capitani et al, 2021, International Journal of Molecular Sciences CrossRef - Research Progress of DCLK1 Inhibitors as Cancer Therapeutics
Linna Cheng et al, 2022, Current Medicinal Chemistry CrossRef - NLRP3 as Putative Marker of Ipilimumab-Induced Cardiotoxicity in the Presence of Hyperglycemia in Estrogen-Responsive and Triple-Negative Breast Cancer Cells
Vincenzo Quagliariello et al, 2020, International Journal of Molecular Sciences CrossRef - Knockdown of Leptin Receptor Affects Macrophage Phenotype in the Tumor Microenvironment Inhibiting Breast Cancer Growth and Progression
Luca Gelsomino et al, 2020, Cancers CrossRef - Natural Killer Cell Engagers (NKCEs): a new frontier in cancer immunotherapy
Minchuan Zhang et al, 2023, Frontiers in Immunology CrossRef - Immunotherapy Study on Non-small-Cell Lung Cancer (NSCLC) Combined with Cytotoxic T Cells and miRNA34a
Richa Pandey et al, 2024, Molecular Pharmaceutics CrossRef - Boron Derivatives Inhibit the Proliferation of Breast Cancer Cells and Affect Tumor-Specific T Cell Activity In Vitro by Distinct Mechanisms
Eslam Essam Mohammed et al, 2023, Biological Trace Element Research CrossRef - Chemokines in progression, chemoresistance, diagnosis, and prognosis of colorectal cancer
Qian Zou et al, 2022, Frontiers in Immunology CrossRef - The expression of FLNA and CLU in PBMCs as a novel screening marker for hepatocellular carcinoma
Rathasapa Patarat et al, 2021, Scientific Reports CrossRef - Synthesis and Preliminary Evaluations of [18F]fluorinated Pyridine-2- carboxamide Derivatives for Targeting PD-L1 in Cancer
Samuel Samnick et al, 2023, Current Cancer Drug Targets CrossRef - PD-L1 Expression Is Associated with Deficient Mismatch Repair and Poor Prognosis in Middle Eastern Colorectal Cancers
Abdul K. Siraj et al, 2021, Journal of Personalized Medicine CrossRef - Determining Factors in the Therapeutic Success of Checkpoint Immunotherapies against PD-L1 in Breast Cancer: A Focus on Epithelial-Mesenchymal Transition Activation
Mariana Segovia-Mendoza et al, 2021, Journal of Immunology Research CrossRef - Mitosis in Cancer Cell Increases Immune Resistance via High Expression of HLA-G and PD-L1
Matti Ullah et al, 2020, Cancers CrossRef - Emerging Insights on Immunotherapy in Liver Cancer
Ying Zhang et al, 2022, Antioxidants & Redox Signaling CrossRef - Fusogenic Hybrid Extracellular Vesicles with PD-1 Membrane Proteins for the Cytosolic Delivery of Cargos
Raga Ishikawa et al, 2022, Cancers CrossRef - Like a Rolling Stone: Sting-Cgas Pathway and Cell-Free DNA as Biomarkers for Combinatorial Immunotherapy
Guillaume Sicard et al, 2020, Pharmaceutics CrossRef - Acquired radioresistance in EMT6 mouse mammary carcinoma cell line is mediated by CTLA-4 and PD-1 through JAK/STAT/PI3K pathway
Nur Fatihah Ronny Sham et al, 2023, Scientific Reports CrossRef - Sensing Soluble Immune Checkpoint Molecules and Disease-Relevant Cytokines in Cancer: A Novel Paradigm in Disease Diagnosis and Monitoring
Nidhi Pandey et al, 2022, Frontiers in Sensors CrossRef - Bifunctional Compounds as Molecular Degraders for Integrin-Facilitated Targeted Protein Degradation
Jiwei Zheng et al, 2022, Journal of the American Chemical Society CrossRef - A Novel Kinase Inhibitor AX-0085 Inhibits Interferon-γ-Mediated Induction of PD-L1 Expression and Promotes Immune Reaction to Lung Adenocarcinoma Cells
Jusong Kim et al, 2021, Cells CrossRef - Clinical applications of liquid biopsy in HPV‐negative and HPV‐positive head and neck squamous cell carcinoma: advances and challenges
Mariana Chantre-Justino et al, 2022, Exploration of Targeted Anti-tumor Therapy CrossRef - Identifying the Phenotypes of Tumor-Derived Extracellular Vesicles Using Size-Coded Affinity Microbeads
Jiacheng Wu et al, 2022, Journal of the American Chemical Society CrossRef - Activation of Host-NLRP3 Inflammasome in Myeloid Cells Dictates Response to Anti-PD-1 Therapy in Metastatic Breast Cancers
Isak W. Tengesdal et al, 2022, Pharmaceuticals CrossRef